Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 191   

Articles published

AZN 4,042.50 +82.50 (2.08%)
price chart
Don't Bank On An AstraZeneca plc Bid Windfall
Shares in AstraZeneca (LSE: AZN) (NYSE: AZN) are currently up around 7% on weekend reports that Pfizer made a tentative bid approach.
Is There Still Time To Buy AstraZeneca plc?
Right now I'm looking at some of the most popular companies in the FTSE 100 and wider market to try and establish if there is still time for investors to buy in.
AstraZeneca PLC (AZN) Climbed To A New High On Pfizer News  RTT News
Pfizer, Inc. Rebuffed: Is AstraZeneca plc Worth Another Try?  Motley Fool
Related articles »  
Pfizer Looking For Another Mega-Merger � This Time With AstraZeneca
American pharmaceutical giant Pfizer Inc. (PFE) has put forward a bid of $100 billion for British AstraZeneca Plc (ADR) (AZN), according to a report published by London-based Sunday Times.
AstraZeneca Plc's Greatest Strengths
When I think of pharmaceutical company AstraZeneca (LSE: AZN) (NYSE: AZN.US), two factors jump out at me as the firm's greatest strengths and top the list of what makes the company attractive as an investment proposition.
Credit Suisse Reiterates �Underperform� Rating for AstraZeneca plc (AZN)
Shares of AstraZeneca plc (NYSE:AZN) traded down 3.24% during mid-day trading on Tuesday, hitting $66.86. The stock had a trading volume of 6,970,894 shares.
AstraZeneca plc (ADR) (AZN) Scheduled to Post Earnings on Thursday  Watch List News (press release)
Recent Analysts' Ratings Updates for AstraZeneca plc (ADR) (AZN)  Ticker Report
Related articles »  
AstraZeneca plc Receives �Underperform� Rating from Credit Suisse (AZN)
AstraZeneca plc logo AstraZeneca plc (LON:AZN)'s stock had its �underperform� rating restated by research analysts at Credit Suisse in a report released on Tuesday, Analyst RN reports.
AstraZeneca PLC (AZN) Is Rising After Reports Of Potential Pfizer Bid
( - The U.K.'sSunday Times reported this weekend that Pfizer ( PFE ) has proposed a $101 billion takeover of AstraZeneca PLC ( AZN ). AstraZeneca gapped open sharply higher Monday morning and is now up 3.62 at $67.11. The stock has ...
Merger Talks Between AstraZeneca plc (ADR) (NYSE:AZN) And Pfizer Inc. (PFE ...
With reports that talks between AstraZeneca plc (ADR) (NYSE:AZN) and Pfizer are currently inactive, it remains to be seen who among the mentioned major drug companies will make a successful bid for AstraZeneca.
AstraZeneca plc (ADR) (NYSE:AZN): Probability Of Second Approach By Pfizer ...
Dallas, Texas 04/22/2014 (ustradevoice) - AstraZeneca plc (ADR) (NYSE:AZN) rejected the huge deal of $101 billion that was offered by Pfizer Inc. (NYSE:PFE) as an attempt to takeover the British Drug Company.
How GlaxoSmithKline plc (GSK) and These Stocks Rescued Biotech Sector ...
While in biotech sector, AstraZeneca PLC (NYSE:AZN), Britain's second-biggest drug maker, has employed a pair of Wall Street investment banks to counsel it on any fresh acquisition move by its bigger U.S.